Laboratory-Developed Tests vs FDA-Approved Assays for BRAF, EGFR, and KRAS Testing

This data analysis compares the analytical validity of US Food and Drug Administration–approved companion diagnostics and laboratory-developed tests for 3 genetic analytes using uniform reference materials from the College of American Pathologists Molecular Oncology Committee.

http://ift.tt/2jTEnC7